Patient Education Blog

Archive for the ‘Andexanet’ Category

Antidote for Pradaxa (Dabigatran): FDA Approval By End of 2015?

| Andexanet, Bleeding, Blood thinners (anticoagulants), Idarucizumab, Therapy | Comments Off on Antidote for Pradaxa (Dabigatran): FDA Approval By End of 2015?

Stephan Moll, MD writes:  A drug in development (Idarucizumab) that reverses the blood thinner Pradaxa® (Dabigatran) is on a very promising path to get FDA approval in the next few months and be available for clinical use by the end of 2015.
Read the rest of this entry »